Annual Report — Form 10-K
Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-K Form 10-K for Period End of December 31, 2004 HTML 811K
2: EX-23.01 Consent of Experts or Counsel 1 6K
3: EX-31.1 Certification per Sarbanes-Oxley Act (Section 302) 2± 10K
4: EX-31.2 Certification per Sarbanes-Oxley Act (Section 302) 2± 10K
5: EX-32 Certification per Sarbanes-Oxley Act (Section 906) 1 8K
EX-23.01 — Consent of Experts or Counsel
EX-23.01 | TOC | ↑Top | Previous | Next | ↓Bottom | Just 1st |
---|
EXHIBIT 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements
(Form S-3 No. 333-120302 and Form S-8 Nos. 333-120579 and 333-110085) of
CancerVax Corporation and in the related Prospectuses of our reports dated March
4, 2005, with respect to: (1) the consolidated financial statements of CancerVax
Corporation, and (2) management's assessment of the effectiveness of internal
control over financial reporting, and the effectiveness of internal control over
financial reporting of CancerVax Corporation, included in this Annual Report
(Form 10-K) for the year ended December 31, 2004.
/s/ Ernst & Young LLP
San Diego, California
March 14, 2005
Dates Referenced Herein
This ‘10-K’ Filing | | Date | | Other Filings |
---|
| | |
Filed on: | | 3/15/05 | | None on these Dates |
| | 3/14/05 |
| | 3/4/05 |
For Period End: | | 12/31/04 |
| List all Filings |
↑Top
Filing Submission 0000950137-05-003048 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
About — Privacy — Redactions — Help —
Tue., Apr. 30, 8:49:51.1am ET